Telix Pharmaceuticals Limited American Depositary Shares
Quarterly Financials
| Values in thousands | 2019-12-31 | 2019-09-30 |
|---|---|---|
Revenue | $7,407 | $6,612 |
Gross Profit | 954 | 1,625 |
EBITDA | -985 | 619 |
EBIT | -1,421 | 239 |
Net Income | -1,580 | 121 |
Net Change In Cash | 7,407 | 6,612 |
Free Cash Flow | 178 | -1,441 |
Cash | 759 | 588 |
Basic Shares | 11,417 | 11,417 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $496,659 | $155,984 | $4,898 | $4,680 |
Gross Profit | 308,502 | 94,428 | 2,350 | 2,656 |
EBITDA | 22,966 | -86,827 | -70,073 | -41,878 |
EBIT | 16,223 | -87,055 | -70,309 | -42,084 |
Net Income | 5,211 | -104,079 | -80,510 | -44,887 |
Net Change In Cash | 496,659 | 155,984 | 4,898 | 4,680 |
Free Cash Flow | -10,794 | -13,861 | -1,339 | -322 |
Cash | 123,237 | 116,329 | 22,037 | 77,945 |
Basic Shares | 323,727 | 316,343 | 285,073 | 280,405 |
